Screener
Gyre Therapeutics, Inc. GYRE PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventories, net | 11,428 | 10,171 |
| Prepaid assets and other current assets | 7,601 | 9,613 |
| Total current assets | 122,072 | 149,362 |
| Property and equipment, net | 27,284 | 27,549 |
| Intangible assets, net | 4,525 | 4,727 |
| Long-term prepayments | 302 | 112 |
| Deferred tax assets | 9,284 | 6,873 |
| Long-term certificates of deposit | 28,444 | 23,516 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s PP&E (net)?
- Gyre Therapeutics, Inc. (GYRE) reported PP&E (net) of $27.28M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Gyre Therapeutics, Inc.'s PP&E (net) increased by 16.6% year-over-year, from $23.4M to $27.28M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s PP&E (net) has grown at a 129.5% compound annual growth rate (CAGR), from $433K to $27.55M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Gyre Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude